Duke Molecular Physiology Institute, Durham, NC, United States.
Division of Nephrology, Duke University Medical Center, Durham, NC, United States.
Sci Rep. 2017 Jan 6;7:39933. doi: 10.1038/srep39933.
Mutations in the LIM homeobox transcription factor 1-beta (LMX1B) are a cause of nail patellar syndrome, a condition characterized by skeletal changes, glaucoma and focal segmental glomerulosclerosis. Recently, a missense mutation (R246Q) in LMX1B was reported as a cause of glomerular pathologies without extra-renal manifestations, otherwise known as nail patella-like renal disease (NPLRD). We have identified two additional NPLRD families with the R246Q mutation, though the mechanisms by which LMX1B causes a renal-specific phenotype is unknown. In this study, using human podocyte cell lines overexpressing either myc-LMX1B or myc-LMX1B, we observed dominant negative and haploinsufficiency effects of the mutation on the expression of podocyte genes such as NPHS1, GLEPP1, and WT1. Specifically, we observed a novel LMX1B-mediated downregulation of WT1(-KTS) isoforms in podocytes. In conclusion, we have shown that the renal-specific phenotype associated with the LMX1B mutation may be due to a dominant negative effect on WT1(-KTS) isoforms that may cause a disruption of the WT1 (-KTS):(+KTS) isoform ratio and a decrease in the expression of podocyte genes. Full delineation of the LMX1B gene regulon is needed to define its role in maintenance of glomerular filtration barrier integrity.
LMX1B 基因中的突变是指甲髌骨综合征的病因之一,该病症的特征是骨骼变化、青光眼和局灶节段性肾小球硬化。最近,报道了 LMX1B 中的一个错义突变(R246Q)是肾小球病变的病因,而没有肾脏外表现,也称为指甲髌骨样肾病(NPLRD)。我们已经确定了另外两个具有 R246Q 突变的 NPLRD 家族,但 LMX1B 导致肾脏特异性表型的机制尚不清楚。在这项研究中,我们使用过表达 myc-LMX1B 或 myc-LMX1B 的人足细胞系,观察到该突变对足细胞基因如 NPHS1、GLEPP1 和 WT1 的表达具有显性负和杂合不足效应。具体而言,我们观察到一种新型的 LMX1B 介导的足细胞中 WT1(-KTS) 异构体的下调。总之,我们已经表明,与 LMX1B 突变相关的肾脏特异性表型可能是由于对 WT1(-KTS) 异构体的显性负作用,这可能导致 WT1(-KTS):(+KTS) 异构体比例的破坏和足细胞基因表达的减少。需要全面描绘 LMX1B 基因调控因子,以确定其在维持肾小球滤过屏障完整性中的作用。